Healthcare >> Analyst Interviews >> December 18, 2000
WILLIAM SLATTERY is a Partner at Deerfield Management Company covering
the biotechnology and healthcare based Internet technologies. He began
his career at the laboratory bench, studying complications associated
with End Stage Renal Disease. Mr. Slattery was previously associated
with Amerindo Investment Advisors, Inc., National Medicine Enterprises,
Lifescan/Johnson & Johnson and HMSS, a division of Secomerica. He
received a BSc degree in Biochemistry from the State University of New
York at Albany and attended the Graduate School of Health at Rutgers. Profile
stocks in 2000?
Mr. Slattery: 2000's outstanding biotechnology stock performance has
been prompted in part by at least
